XML 204 R196.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE II - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Balance Sheets) (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Assets        
Derivative investments $ 3,594 $ 5,697    
Other investments 3,739 4,288    
Cash and invested cash 3,343 2,612 $ 1,708 $ 2,563
Other assets 18,802 16,532    
Total assets 334,217 394,750    
Liabilities        
Short-term debt 500 300    
Long-term debt 5,955 6,325    
Payables for collateral on investments 6,712 8,946    
Other liabilities 12,021 16,405    
Total liabilities 329,115 374,835    
Contingencies and Commitments    
Stockholders' Equity        
Common stock - 800,000,000 shares authorized 4,544 4,735    
Retained earnings 5,924 5,196    
Accumulated other comprehensive income (loss) (6,352) 9,984    
Total stockholders' equity 5,102 19,915 22,699  
Total Liabilities and Stockholders' Equity 334,217 394,750    
Series C Preferred Stock [Member]        
Stockholders' Equity        
Preferred stock - 10,000,000 shares authorized 493      
Series D Preferred Stock [Member]        
Stockholders' Equity        
Preferred stock - 10,000,000 shares authorized 493      
Parent Company [Member]        
Assets        
Investments in subsidiaries 9,782 24,332    
Derivative investments 119      
Other investments 92 761    
Cash and invested cash 715 203 $ 114 $ 577
Loans and accrued interest to subsidiaries 2,491 3,194    
Other assets 101 159    
Total assets 13,300 28,649    
Liabilities        
Common stock dividends payable 76 80    
Derivative investments liability   425    
Short-term debt 500 300    
Long-term debt 6,455 6,325    
Loans from subsidiaries 679 1,247    
Other liabilities 488 357    
Total liabilities 8,198 8,734    
Stockholders' Equity        
Common stock - 800,000,000 shares authorized 4,544 4,735    
Retained earnings 5,924 5,196    
Accumulated other comprehensive income (loss) (6,352) 9,984    
Total stockholders' equity 5,102 19,915    
Total Liabilities and Stockholders' Equity 13,300 $ 28,649    
Parent Company [Member] | Series C Preferred Stock [Member]        
Stockholders' Equity        
Preferred stock - 10,000,000 shares authorized 493      
Parent Company [Member] | Series D Preferred Stock [Member]        
Stockholders' Equity        
Preferred stock - 10,000,000 shares authorized $ 493